Female Infertility, Menopause, and Contraceptive Drugs Market: Global Industry

Analysis and Forecast 2014 - 2020

Persistence Market Research

Female Infertility, Menopause, and

Contraceptive Drugs Market: Global Industry
Analysis and Forecast 2014 - 2020

Persistence Market Research

Female Infertility, Menopause, and Contraceptive Drugs Market: Global Industry

Analysis and Forecast 2014 - 2020

Persistence Market Research Released New Market Report on Female Infertility,

Menopause, and Contraceptive Drugs Market: Global Industry Analysis and Forecast
2014 - 2020.
Menopause, also termed as climacteric, refers to cessation of menstruation. It usually occurs in females
aged between 45 and 55 years. Female infertility refers to a condition of infertility in females. Various
causes for female infertility are polycystic ovary syndrome (PCOS), hypothalamic dysfunction, premature
ovarian insufficiency, and hyperprolactinemia. Contraceptives are drugs and devices that are used to
prevent pregnancy and sexually transmitted infections. Contraceptive drugs are further classified as
contraceptive pills, topical contraceptives, and contraceptive injectables. The female infertility,
menopause, and contraceptive drugs market is growing at a significant rate due to increasing disorders
related to fertility and menopause and rising awareness about different menopause, female infertility and
contraceptive drugs. In addition, government initiatives for improving female health are driving the market
for female infertility, menopause, and contraceptive drugs.

Buy Full Report: http://www.persistencemarketresearch.com/market-research/female-infertilitymenopause-contraceptive-drugs-market.asp

North America dominates the global market for female infertility, menopause and contraceptive drugs due
to the increasing prevalence of disorders related to menopause and female infertility in the region. In
addition, high usage of contraceptive pills in the region due to the high efficiency provided by the drugs is
driving the overall market for contraceptives. Asia, followed by Europe, is expected to experience high
growth rate in the next few years in the female infertility, menopause, and contraceptive drugs market.
China and India are expected to be the fastest growing female infertility, menopause, and contraceptive
drugs markets in Asia. Some of the key driving forces for the female infertility, menopause and
contraceptive drugs market in emerging countries are large pool of patients and rising government
initiatives by funding and strict laws.

Increasing awareness about different disorders in female fertility, menopause, and complications in
female health by not using birth control measures is contributing to the growth of the market for female
infertility, menopause and contraceptive drugs. In addition, the increasing prevalence of female sexual
disorders and improvement in healthcare facilities and technological advancements in the field have been
driving the female infertility, menopause, and contraceptive drugs market. However, the side effects

Persistence Market Research

Female Infertility, Menopause, and Contraceptive Drugs Market: Global Industry

Analysis and Forecast 2014 - 2020
associated with the intake of contraceptive drugs and lower adoption rates for drugs associated with
treatment of female infertility and menopause have been restraining the market.

Growing populations and developing economies in countries such as India and China are expected to
offer good opportunities for the global female infertility, menopause, and contraceptive drugs market. The
arrival on the market of some new products with better efficiency is expected to offer good opportunity for
the global female infertility, menopause, and contraceptive drugs market. The growing number of mergers
and acquisitions, new product launches, and increasing number of collaborations and partnerships are
some of the latest trends that observed in the global female infertility, menopause and contraceptive
drugs market. The side effects associated with intake of female infertility, menopause, and contraceptive
drugs are a challenge for the market. Some of the major companies dealing in global menopause, fertility
and contraceptive drugs market include Aventis SA, Bristol-Myers Squibb Company, Johnson & Johnson,
and Merck & Company, Inc. Other significant players in the global menopause, fertility, and contraceptive
drugs market include Novartis International AG, Bayers AG, Pharmacia & Upjohn, Inc., Organon, Inc.,
Berlex Laboratories, Parke-Davis, G. D. Searle & Company, TAP Holdings Inc., The Ares-Serono Group,
and American Home Products Corporation.

Request Full TOC: http://www.persistencemarketresearch.com/toc/4280

Key points covered in the report:1. Report segments the market on the basis of types, application, products, technology, etc
(as applicable)
2. The report covers geographic segmentation
North America
Europe
Asia
RoW
3. The report provides the market size and forecast for the different segments and
geographies for the period of 2010 to 2020
4. The report provides company profiles of some of the leading companies operating in the
market
5. The report also provides porters five forces analysis of the market.
Browse the full All Upcoming Persistence Market's report at
http://www.persistencemarketresearch.com/forthcoming-reports.asp
About Us:

Persistence Market Research

Female Infertility, Menopause, and Contraceptive Drugs Market: Global Industry

Analysis and Forecast 2014 - 2020

Persistence Market Research is a global market research firm specializing- syndicated

research, custom research, and consulting services
At Persistence Market Research (PMR), we are in the business of accelerating your business.
As a full-service market research firm, we stand committed to bringing more accuracy and
speed to your business decisions. From ready-to-purchase market research reports to
customized global research solutions, our engagement models are highly flexible without
compromising on our deep-seated research values. Briefly stated, our mission is to give you
access to forecasts and trends analyses that put you on the path to profitability.
PMRs Services Go Beyond Gleaning Data:
Most enterprises believe that IT and databases are enough to make an accurate decision. While
we do not dispute that, consider this: How long does it take to make an accurate and strategic
million-dollar decision? We strive to deliver both even with demanding deadlines.

Facilitating Rapid and Informed Business Decisions

PMR was founded with one goal in mind: to offer enterprises a tangible business advantage by
carefully balancing traditional and modern-day research methodologies.
Contact Us:
Addie Thomes
305 Broadway,
7th Floor,
New York City, NY 10007,
United States.
Phone: +1-646-568-7751
USA/Canada Toll Free Number.
1-800-961-0353
E-mail: Sales@persistencemarketresearch.com
Web : http://www.persistencemarketresearch.com/

Persistence Market Research